There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
Show figures in :Show figures in :
Data is unavailable
Data is unavailable
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2008 | FY 2007 | FY 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net worth | 1267.29 | 1169.47 | 688.65 | 647.38 | 652.91 | 765.98 | -704.04 | -791.76 | -387.67 | 49.04 | 664.98 | 485.10 | 775.59 |
| Fixed assets | 632.71 | 620.23 | 573.09 | 583.70 | 670.45 | 857.93 | 1256.26 | 1386.20 | 1496.54 | 1636.83 | 1539.95 | 1105.40 | 990.44 |
| Debt | 174.24 | 134.48 | 331.35 | 267.95 | 452.74 | 566.39 | 3229.96 | 3201.95 | 3106.16 | 3214.59 | 1970.54 | 1648.80 | 1044.96 |
View detailed balance sheet
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 19.22 | 125.99 | 18.34 | 92.47 | 23.59 | 80.80 | 12.02 | 9.18 | 317.01 | 212.20 |
| Investing | -26.93 | -312.03 | -31.21 | 112.94 | 67.21 | 167.11 | 45.47 | -28.06 | -8.59 | -1.46 |
| Financing | 25.22 | 167.04 | 31.17 | -216.80 | -164.99 | -250.33 | -0.30 | 33.39 | -366.30 | -286.36 |
Orchid develops, manufactures, and markets APIs, formulations, and nutraceuticals; it operates USFDA-compliant API and FDF sites and GLP-compliant R&D facilities in Chennai, with exports to 40+ countries.
Dhanuka Laboratories Limited became the parent after implementing the approved resolution plan on March 31, 2020, via an SPV that later merged into Orchid.
Standalone revenue from operations was Rs 921.93 crore and EPS was Rs 20.99 (basic and diluted) for FY 2024–25.
